These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31592798)

  • 1. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
    Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
    Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
    Warmke LM; Meis JM
    Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
    Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
    Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
    Mohamed M; Fisher C; Thway K
    Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
    Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
    Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing Epithelioid Fibrosarcoma.
    Warmke LM; Yu W; Meis JM
    Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.
    Kosemehmetoglu K; Ardic F; Kilpatrick SE; Aydingoz U; Sumathi VP; Michal M
    Virchows Arch; 2021 Apr; 478(4):767-777. PubMed ID: 33084978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.
    Tsuda Y; Dickson BC; Dry SM; Federman N; Suurmeijer AJH; Swanson D; Sung YS; Zhang L; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Apr; 59(4):217-224. PubMed ID: 31675134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing epithelioid fibrosarcoma.
    Patterson JW; Tchernev G; Chokoeva AA; Wick MR
    Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing epithelioid fibrosarcoma of the spine: a single-institution experience.
    Righi A; Pacheco M; Pipola V; Gambarotti M; Benini S; Sbaraglia M; Frisoni T; Boriani S; Dei Tos AP; Gasbarrini A
    Histopathology; 2021 Jun; 78(7):976-986. PubMed ID: 33428796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
    Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
    Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
    [No Abstract]   [Full Text] [Related]  

  • 16. Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor.
    Murshed KA; Al-Bozom I; Ammar A
    APMIS; 2021 Aug; 129(8):455-460. PubMed ID: 34048081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KMT2A (MLL) fusions in aggressive sarcomas in young adults.
    Yoshida A; Arai Y; Tanzawa Y; Wakai S; Hama N; Kawai A; Shibata T
    Histopathology; 2019 Oct; 75(4):508-516. PubMed ID: 31136005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
    Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
    J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
    Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
    Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children.
    Zhang M; Yu Y; Guan X; Yao X; Jia C; Hong E; Guo Y; He L
    Pathol Res Pract; 2022 Feb; 230():153754. PubMed ID: 34990868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.